How Long Does Bacteriostatic Water Last After Opening?
Where the 28-day figure for an opened multi-dose vial comes from, what USP and the CDC actually say, and why the water's clock is not the peptide's clock.
Research use only. This page provides scientific background and community-report context. Every compound sold here is supplied strictly for in-vitro research, not for administration to a person or animal. Nothing on this page is a protocol, a recommendation, or medical advice.
TL;DR: a guideline date is not a stability measurement
The question people actually type: how long is bacteriostatic water good for after opening, and where does the CDC's 28-day figure come from?
What the published data say: the CDC cites USP <797> for a 28-day post-puncture limit for multi-dose vials unless the manufacturer specifies another opened-vial date, capped by the original expiry. [CDC-1]
What this test does not establish: the USP <51> test does not establish the lifespan of a repeatedly accessed water vial; its effectiveness criteria apply to the original, unopened container. [U51]
What research communities report: in the Reddit corpus we track, 215 question posts in the 12-month corpus and 9 question posts in the separate 4 to 12 Sept 2026 corpus, matched the bacteriostatic-water shelf-life regex. These are reports, not evidence of frequency or usable lifespan. [Community corpus]
Where does the 28-day figure come from?
The CDC attributes the 28-day opened multi-dose vial rule to USP <797>, with an exception when the manufacturer states another date for the opened vial. The CDC also states that the beyond-use date cannot exceed the manufacturer's original expiration date. Its wording names needle puncture as the example of a vial being opened. [CDC-1]
The CDC's 28 days is a compendial and guideline rule, not a measured shelf life. The separate USP <51> antimicrobial effectiveness test also spans 28 days, but its stated scope is the product in its original, unopened container. That is a preservative challenge, not an observation of ordinary opened-vial use. [CDC-1; U51]
The PubMed search USP 797 multiple dose container beyond use date 28 days, performed on 2026-09-13, returned 0 records. This documents the search result; the affirmative basis for the dating rule remains the CDC's account of USP <797>. It does not establish that a vial changes chemically at the guideline boundary. [CDC-1; documented PubMed search]
Does the label itself state an in-use date?
The Hospira label reviewed here states no in-use period after first puncture. The full-text search documented on 2026-09-13 found 0 matches for the specified opened-vial and duration terms. That absence fits the CDC's 28-day default for cases without a different manufacturer-specified opened-vial date. [LAB-H; CDC-1]
For unopened multi-dose vials, the CDC refers to the manufacturer's expiration date. The Hospira label gives a storage range of 20 to 25 C; that labeled condition does not itself supply an opened-vial lifespan. [CDC-1; LAB-H, HOW SUPPLIED]
The live manufacturer-report record retrieved on 2026-09-13 lists Canvax Reagents, batch E26072903, test date 2026-08-17, and a microbial pass. Its CoA states expiration 07/2028 and describes analysis at manufacture; it states no in-use period. These are release-document facts, not measurements of opened-vial longevity. [Canvax CoA; live lab-report record]
The separate vendor versus pharma-grade water page covers specifications, pH, and CoA interpretation. The bacteriostatic-water overview covers the commercial context.
What does the preservative do, and what does it not do?
USP <51> describes antimicrobial preservatives as agents added to inhibit microorganism growth; the CDC says they provide neither complete protection against bacterial contamination nor an effect on viruses. Bacteriostatic therefore does not mean that all contamination is eliminated. [U51; CDC-1]
The USP <51> Category 1 criteria distinguish bacterial reduction from control of yeast and molds. Each comparison below belongs to that laboratory challenge. [U51, Table 3]
- Bacterial criterion
- At least 1.0 log reduction
- Comparator
- Initial calculated count
- Yeast and molds criterion
- No increase from initial count
- Bacterial criterion
- At least 3.0 log reduction
- Comparator
- Initial calculated count
- Yeast and molds criterion
- No increase from initial count
- Bacterial criterion
- No increase
- Comparator
- Bacterial count at 14 days
- Yeast and molds criterion
- No increase from initial count
USP <51> defines “no increase” as no more than 0.5 log10 above the previous measured value. The phrase is an analytical tolerance, not a claim that every organism has been killed. The chapter also says preservatives cannot replace good manufacturing practices. [U51, CRITERIA and opening paragraphs]
The CDC treats compromised or questionable sterility as a reason a medication vial is no longer usable regardless of its date. A calendar limit is therefore only part of the CDC's guidance on vial contamination. [CDC-1]
What do studies report about opened multi-dose vials in real use?
Published studies report differing contamination findings in opened multi-dose vials, rather than a consistent time at which contamination begins. Schubert examined 351 vials in use for 6 to 48 days and reported that no vial yielded bacteria. [Schubert 1985, PMID 3994029]
Mattner reported contamination in 1 of 227 vials and in 1 spike, with a reported combined contamination rate of 0.9%. That 0.9% is the authors' combined rate for both findings, not a vial-only rate. Motamedifar reported bacterial contamination in 36 of 637 vials, or 5.6%. These are separate study populations, not a controlled comparison of vial ages. [Mattner 2004, PMID 14755229; Motamedifar 2009, PMID 19362388]
In Berg's experimental study, 12 preserved vials were followed for 6 months, producing 454 cultured samples. The authors reported no identified vial contamination, while noting a sample with non-repeatable growth. That observation concerns the studied conditions; it does not establish a general opened-water expiration date. [Berg 2023, PMID 37559404]
Does the 28-day clock also apply to the reconstituted peptide?
The CDC's 28-day opened-vial rule does not establish a reconstituted peptide's chemical stability. The water vial's post-puncture period says nothing about how long a reconstituted peptide stays chemically stable. That clock comes from peptide-specific stability data. [CDC-1; LAB-H, PRECAUTIONS]
The Hospira label states: “Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.” The label thus refers storage of the made-up solution to the solute manufacturer's directions. Its water-vial information cannot supply missing peptide-specific stability evidence. [LAB-H, PRECAUTIONS]
Differences between diluents belong in the existing bacteriostatic, acetic acid, and sterile water comparison.
Products mentioned
USP-grade sterile water with 0.9% benzyl alcohol (near-neutral, pH 6.2 to 6.4) - the standard solvent for reconstituting lyophilized peptides. Essential accessory for any peptide research. Each vial is sealed and ready to use.
Sources
- CDC, 2024. Preventing Unsafe Injection Practices. CDC-1: https://www.cdc.gov/injection-safety/hcp/clinical-safety/index.html
- USP. USP <51>, USP32-NF27, p. 67. U51, opening, CRITERIA, and Table 3.
- Hospira / Pfizer Healthcare India, rev 08/2019. DailyMed label, PRECAUTIONS, HOW SUPPLIED. LAB-H, setid 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7.
- Schubert, 1985. Opened-vial study: “No vial yielded bacteria.” PMID 3994029.
- Mattner, 2004. Opened-vial study: “1 vial and 1 spike were contaminated with Staphylococcus epidermidis”. PMID 14755229.
- Motamedifar, 2009. Opened-vial study: “Bacterial contamination was identified in 36 of 637 (5.6%) of vials”. PMID 19362388.
- Berg, 2023. Preserved-vial study: “Microbial contamination was not identified in any vial throughout the study period.” PMID 37559404.
- Canvax, 2026. CoA, lot E26072903, verified 17 Aug 2026: https://peptidesdirect.io/media/pep-shop/documents/canvax-bac-water-e0329-lot-e26072903-coa.pdf
- PeptidesDirect, 2026. Live lab-report record, retrieved 2026-09-13: https://api.peptidesdirect.io/products/lab-reports
- PubMed, 2026-09-13. Documented search:
USP 797 multiple dose container beyond use date 28 days, 0 records. - Community corpus, 2026. Bacteriostatic-water shelf-life regex audit:
.scratch/reddit-corpus/question-posts.jsonland.scratch/reddit-corpus/delta2/questions.json, counts documented 2026-09-13.
Research use only. Materials sold here are supplied strictly for in-vitro research, not for human or animal administration. Nothing on this page is an application protocol or medical advice.
Research context for English-speaking buyers
Most of our English-speaking customers ship to the UK, Ireland, Malta or other English-as-second-language EU territories. The regulatory picture differs per country.
- Relevant authorities
- MHRA (UK, post-Brexit), HPRA (Ireland, EU-aligned), FDA Section 503A bulks list (US, restricted Cat 2 status of several peptides as of 2026)
- Customs and VAT
- EU shipments include VAT, the rate depends on the destination country; UK shipments after Brexit are now extra-EU and may attract UK VAT plus a handling fee at import
- Typical shipping window
- EU 2-4 working days, UK 4-7 working days, other international 7-14 working days, depending on customs
Research-grade peptides shipped from our EU warehouse are sold for laboratory use only and are not authorised for human or veterinary therapeutic application in any of the destination jurisdictions. US customers should be aware that the FDA Section 503A bulks list classification (and the April 2026 reclassification of twelve compounds) only governs compounding pharmacies, not direct-to-researcher imports for non-clinical work. UK buyers should declare the consignment on import and may be asked for a research justification by HMRC. We provide a CoA per batch identified by colour code rather than serial number; customs sometimes asks for this document when clearing the parcel.